IMCC

+ Watchlist + Portfolio

IM Cannabis Corp.

Regulated industry Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.17
52-Week Range: $1.55 – $77.10
Market Cap: $3.36M
P/E (TTM): —
EPS (TTM): -71.41
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -18.57%
Gross Margin: 12.53%
Operating Margin: -27.54%
Profit Margin: -39.13%
Current Ratio: 0.56
Debt/Equity: —
Total Debt: $13.83M
Free Cash Flow: $-2.13M
Revenue Growth: -40.20%
Earnings Growth: —
Enterprise Value: $13.23M

IMCC Income statement, annual periods, in CAD
CAD	FY2022	FY2023	FY2024	FY2025
Revenue	$54.34M	$48.80M	$54.03M	$54.73M
Cost of Revenue	$45.17M	$38.96M	$45.58M	$45.05M
Gross Profit	$9.16M	$9.85M	$8.45M	$9.69M
Selling, General & Admin	$28.91M	$19.03M	$13.28M	$12.94M
Operating Expenses	$31.66M	$22.02M	$18.68M	$21.27M
Operating Income	-$22.50M	-$12.18M	-$10.23M	-$11.59M
EBITDA	-$16.76M	-$4.75M	-$8.10M	-$6.95M
Pretax Income	-$26.06M	-$9.46M	-$12.79M	-$11.66M
Income Tax	-$1.14M	$771.00K	-$1.02M	$92.00K
Net Income	-$188.89M	-$9.50M	-$10.59M	-$11.32M
Diluted EPS	-161.88	-4.45	-4.51	-2.67
Diluted Shares	1.20M	2.13M	2.35M	4.24M

IMCC Balance Sheet statement, annual periods, in CAD
CAD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$2.45M	$1.81M	$863.00K	$2.73M
Receivables	$10.52M	$11.33M	$16.68M	$12.98M
Inventory	$16.59M	$9.98M	$3.21M	$4.27M
Current Assets	$32.67M	$24.27M	$23.36M	$22.74M
Total Assets	$60.68M	$48.81M	$39.19M	$31.74M
Current Liabilities	$33.82M	$32.85M	$34.92M	$34.01M
Long-Term Debt	$399.00K	$394.00K	$466.00K	$936.00K
Total Debt	$11.53M	$13.78M	$18.01M	$16.27M
Total Liabilities	$36.88M	$35.11M	$36.04M	$35.35M
Retained Earnings	-$239.57M	-$249.15M	-$258.94M	-$270.21M
Shareholders' Equity	$22.65M	$14.47M	$5.24M	-$858.00K
Working Capital	-$1.15M	-$8.58M	-$11.55M	-$11.27M
Net Debt	$7.20M	$10.70M	$16.72M	$13.16M

IMCC Cash Flow statement, annual periods, in CAD
CAD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$12.64M	-$8.07M	-$1.08M	$4.72M
Capital Expenditure	-$1.56M	-$581.00K	-$156.00K	-$13.00K
Free Cash Flow	-$14.20M	-$8.66M	-$1.23M	$4.70M
Depreciation & Amortisation	$7.33M	$3.00M	$2.18M	$1.96M
Stock-Based Compensation	$3.77M	$225.00K	$369.00K	$14.00K
Investing Cash Flow	-$1.53M	-$1.18M	-$470.00K	-$531.00K
Financing Cash Flow	$4.76M	$9.42M	$3.83M	$1.15M
Dividends Paid	$0.00	$0.00	$0.00	$0.00
Net Change in Cash	-$9.41M	$160.00K	$2.28M	$5.33M

IMCC Income statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$12.50M	$12.70M	$13.85M	$15.68M	$8.68M	—
Cost of Revenue	$9.05M	$9.27M	$11.12M	$15.60M	$7.26M	—
Gross Profit	$3.45M	$3.42M	$2.73M	$82.00K	$1.42M	—
Selling, General & Admin	$3.29M	$3.77M	$3.81M	$2.06M	$3.10M	—
Operating Expenses	$3.29M	$3.77M	$3.81M	$10.40M	$3.10M	—
Operating Income	$158.00K	-$350.00K	-$1.08M	-$10.32M	-$1.68M	—
EBITDA	$621.00K	$2.01M	-$2.54M	-$7.22M	-$1.18M	—
Pretax Income	$146.00K	-$220.00K	-$3.72M	-$7.86M	-$2.51M	—
Income Tax	-$29.00K	-$26.00K	$141.00K	$6.00K	-$41.00K	—
Net Income	$275.00K	-$309.00K	-$3.65M	-$7.63M	-$2.28M	—
Diluted EPS	0.09	-0.09	-0.75	—	-0.38	-0.47
Diluted Shares	3.08M	3.26M	4.86M	—	5.93M	9.27M

IMCC Balance Sheet statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$1.39M	$1.39M	$794.00K	$1.18M	$2.73M	$1.00M
Receivables	$16.65M	$16.65M	$20.95M	$11.26M	$12.98M	$7.17M
Inventory	$5.43M	$5.43M	$3.66M	$10.02M	$4.27M	$2.00M
Current Assets	$29.52M	$29.52M	$25.44M	$31.67M	$22.74M	$15.12M
Total Assets	$44.93M	$44.93M	$41.07M	$44.33M	$31.74M	$23.70M
Current Liabilities	$40.79M	$40.79M	$35.15M	$38.46M	$34.01M	$27.72M
Long-Term Debt	$314.00K	$314.00K	$1.30M	$1.08M	$936.00K	$785.00K
Total Debt	$15.78M	$15.78M	$15.65M	$17.56M	$16.27M	$14.96M
Total Liabilities	$41.76M	$41.76M	$37.01M	$40.03M	$35.35M	$28.82M
Retained Earnings	-$258.63M	-$258.63M	-$258.93M	-$262.58M	-$270.21M	-$272.38M
Shareholders' Equity	$5.32M	$5.32M	$3.52M	$3.96M	-$858.00K	-$5.05M
Working Capital	-$11.27M	-$11.27M	-$9.71M	-$6.79M	-$11.27M	-$12.60M
Net Debt	$13.88M	$13.88M	$14.40M	$15.91M	$13.16M	$13.70M

IMCC Cash Flow statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$4.46M	$4.46M	-$474.00K	-$3.50M	$4.22M	-$186.00K
Capital Expenditure	—	—	—	-$4.00K	-$5.00K	-$5.00K
Free Cash Flow	$4.46M	$4.46M	-$478.00K	-$3.50M	$4.22M	-$191.00K
Depreciation & Amortisation	$463.00K	$463.00K	$471.00K	$501.00K	$521.00K	$497.00K
Stock-Based Compensation	$8.00K	$8.00K	$4.00K	$2.00K	$0.00	$0.00
Investing Cash Flow	$0.00	$0.00	$19.00K	-$1.10M	$547.00K	$429.00K
Financing Cash Flow	-$2.87M	-$2.87M	$45.00K	$6.09M	-$2.12M	-$933.00K
Dividends Paid	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Net Change in Cash	$1.59M	$1.59M	-$410.00K	$1.50M	$2.65M	-$690.00K

Market Snapshot

About

IM Cannabis Corp. is an international cannabis company that focuses on the medical and adult-use cannabis markets in Israel, Germany, and Canada. The company operates through cultivation, distribution, and retail segments, offering a range of cannabis products including dried flower, oils, and extracts. IM Cannabis has established strategic partnerships and distribution agreements to expand its market reach. The company leverages its Israeli operations and expertise to serve growing European medical cannabis markets.